Aspergillus fumigatus peritonitis in ambulatory peritoneal dialysis: A case report and notes on the therapeutic approach

Nephrology

Volumn 10, Issue 3, 2005, Pages 270-273

  Bonfante, Luciana ^a   Nalesso, Federico ^a   Cara, Marilena ^a   Antonello, Augusto ^a   Malagoli, Andrea ^a   Pastori, Giordano ^a   Guizzo, Marta ^a   D'Angelo, Angela ^a   Gambaro, Giovanni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aspergillus fumigatus; Automated peritoneal dialysis; Peritonitis

Indexed keywords

AMPHOTERICIN B;

AGED; ARTICLE; ASPERGILLUS FUMIGATUS; AUTOMATION; CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; MORTALITY; NAUSEA; PERITONEAL CATHETER; PERITONITIS; PRIORITY JOURNAL; RARE DISEASE; SHIVERING; VOMITING;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ITRACONAZOLE; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 21344462193     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00370.x     Document Type: Article

References (26)

1. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int. 1993; 43 (Suppl.): S4-15.
2. Holley JL, Bernardini J, Piraino B. Infecting organisms in continuous ambulatory peritoneal dialysis patient on the Y-set. Am. J. Kidney Dis. 1994; 23: 569-73.
3. Kerr CM, Perfect JR, Craven PC et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 1983; 99: 334-7.
4. Eisenberg E, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev. Infect. Dis. 1986; 8: 309-21.
5. Levitz SM, Di Benedetto DJ. Aspergillosis. Infect. Dis. Clin. North. Am. 1989; 3: 1-18.
6. Nannini EC, Paphitou NI, Ostrosky-Zeichner L. Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: Report of 2 cases and review of the literature. Diagn. Microbiol. Infect. Dis. 2003; 46: 49-54.
7. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 1996; 23: 608-15.
8. Tanis BC, Verburgh CA, van't Wout JW, van der Pijl JW. Aspergillus peritonitis in peritoneal dialysis: A case report and a review of the literature. Nephrol. Dial. Transplant. 1995; 10: 1240-43.
9. Geiss HK. Peritoneal aspergillosis - pitfalls in the diagnosis of a rare disease. Nephrol. Dial. Transplant. 1995; 10: 1124-5.
10. Kappe R, Rimek D. Laboratory diagnosis of Aspergillus fumigatus-associated diseases. Contrib. Microbiol. 1999; 2: 88-104.
11. Miles AM, Barth RH. Aspergillus peritonitis: Therapy, survival and return to peritoneal dialysis. Am. J. Kidney Dis. 1995; 26: 80-83.
12. Keane WF, Bailie GR, Boeschoten E et al. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Pent. Dial. Int. 2000; 20: 396-411.
13. Rubin J, Kirchner K, Walsh D, Green M, Bower J. Fungal peritonitis during continuous ambulatory peritoneal dialysis: A report of 17 cases. Am. J. Kidney Dis. 1987; 10: 361-8.
14. Saklayen MG. CAPD peritonitis. Incidence, patogens, diagnosis and management. Med. Clin. North Am. 1990; 74: 997-1010.
15. Nagappan R, Collins JF, Lee WT. Fungal peritonitis in continuous ambulatory peritoneal dialysis. The Auckland experience. Am. J. Kidney Dis. 1992; 20: 492-6.
16. Basok A, Schneider E, Hausmann M, Rapoport J. Aspergillus peritonitis in continuous ambulatory peritoneal dialysis patients. Am. J. Nephrol. 2000; 20: 329-31.
17. Park SB, Kim KH, Joo I, Kim HC. Scanning electron microscopy studies of peritoneal catheter in CAPD peritonitis due to Aspergillus fumigatus. Perit. Dial. Int. 1996; 16: 81-3.
18. Stein M, Levine JF, Black W. Successful treatment of aspergillus peritonitis in an adult on continuous ambulatory peritoneal dialysis. Nephron 1991; 59: 145-7.
19. Lin S-J, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: Systematic review of the literature. Clin. Infect. Dis. 2001; 32: 358-66.
20. Denning DW, Marinus A, Cohen J et al. An EORTC multicentre prospective survey of invasive aspergillosis in haemotalogical patients: Diagnosis and therapeutic outcome. EORTC invasive fungal infections cooperative group. J. Infect. 1998; 37: 173-80.
21. Kontoyiannis DP, Matadakis E, Samonis G. Systemic mycosis in the immunocompromised host: An update in antifungal therapy. J. Hosp. Infect. 2003; 53: 243-58.
22. Ellis M. Amphothericin B preparations: A maximum tolerated dose in severe invasive fungal infections? Transpl. Infect. Dis. 2000; 2: 51-61.
23. Stevens DA, Kan VL, Judson MA et al. Practice guidelines for disease caused by Aspergillus. Clin. Infect. Dis. 2000; 30: 679-83.
24. Ronald ARKJ (ed). Physicians' Desk Reference, 50th edn. Montvale, NJ: Medical Economics Company, 1996; 506-7.
25. Prewitt K, Lockard J, Rodgers D, Hasbargen J. Successful treatment of Aspergillus peritonitis complicating peritoneal dialysis. Am. J. Kidney Dis. 1989; 13: 501-3.
26. Matsumoto N, Shiraga H, Takahashi K, Kikuchi K, Ito K. Successful treatment of Aspergillus peritonitis in a peritoneal dialysis patient. Pediatr. Nephrol. 2002; 17: 243-5.